Drug Discount Monitor

The Inside Source on the Public Health Service 340B Drug Discount Program

Safety Net Hospitals for Pharmaceutical Access

Welcome!
You are currently logged in.

View Archived Articles Here


October 2009 Headlines

AWP Re-Calculation Will Squeeze 340B Margins

October 26, 2009 - First Data Bank and Medi-Span are reducing average wholesale acquisition pricing data for 7,000-some drugs under a recent court settlement. It could cost pharmacies dearly. Read more

340B Providers Net $7.3 Million in Medicaid False Claims Settlement

October 20, 2009 - Another False Claims case has been settled, and another round of checks will soon be in the mail to 340B providers. This time they will receive almost $7.3 million. Read more

Children's Hospital of Michigan is First to Enroll in 340B

October 19, 2009 - The hospital was first out of the gate in early 2006, and first to join the drug discount program now that federal guidelines are finally in place. The Detroit institution says its savings will be "significant." Read more

Coordinated Care – Another Way to Pay for Health Reform?

October 19, 2009 - How about saving Medicare and Medicaid $133 billion-plus a year, and private plans almost $107 billion? Coordinated care can do magic, consultant says. Read more

OIG's 2010 Work Plan Probes 340B Reimbursements

October 19, 2009 - The U.S. Health and Human Services' investigative arm is examining how safety-net providers get paid by Medicaid and Medicare for outpatient drugs. The OIG also wants to know if drug makers report prices in a timely manner. Read more

NDC Reporting Not Mandated for Outpatient Drugs, CMS Says

October 9, 2009 - Safety-net hospitals get federal relief from a controversial reporting policy that was costing some millions of dollars to implement. It's now up to states whether or not to require the NDCs. Read more

Ohio Carve-Out Ban Failed; Other States Press On

October 7, 2009 - Financially strapped states continue to seek ways to trim Medicaid reimbursements for 340B providers. Who's next on the carve-out no-no list? Read more